The Canadian apheresis registry (Q47663642)

4 February 2018

title

The Canadian apheresis registry (English)

1 reference

4 February 2018

author name string

G Rock

1

1 reference

4 February 2018

B Clark

2

1 reference

4 February 2018

D Sutton

3

1 reference

4 February 2018

CAG

4

1 reference

4 February 2018

CAAN

5

1 reference

4 February 2018

publication date

1 October 2003

1 reference

4 February 2018

Transfusion and Apheresis Science

published in

1 reference

4 February 2018

volume

29

1 reference

4 February 2018

issue

2

1 reference

4 February 2018

page(s)

167-177

1 reference

4 February 2018

Treatment of Guillain-Barré syndrome: a cost-effectiveness analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Long-term use of antecubital veins for plasma exchange. The Canadian Cooperative Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Plasmapheresis therapy in rheumatoid arthritis. A controlled, double-blind, crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Complications of plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

Homozygous familial hypercholesterolemia. Selective removal of low-density lipoproteins by secondary membrane filtration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2803%2900111-3

7 January 2021

10.1016/S1473-0502(03)00111-3

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018